Section Arrow
Quote
ALKS.NASDAQ
- Alkermes plc
Quotes are at least 15-min delayed:2025/02/23 04:21 EST
Last
 35.32
-0.18 (-0.51%)
Day High 
35.79 
Prev. Close
35.5 
1-M High
36.45 
Volume 
1.06M 
Bid
34.51
Ask
36.36
Day Low
35.09 
Open
35.79 
1-M Low
29.68 
Market Cap 
5.77B 
Currency USD 
P/E 16.14 
%Yield -- 
10-SMA 33.88 
20-SMA 32.65 
50-SMA 30.85 
52-W High 36.45 
52-W Low 22.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.17/1.23
Enterprise Value
5.84B
Balance Sheet
Book Value Per Share
9.01
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
1.56B
Operating Revenue Per Share
9.78
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed：2025/02/23 04:21 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.